Purna: Advancing Pharmaceutical Innovation – Partnering for the Future of Wound Healing

Purna is a Belgian Pharmaceutical CDMO established in 1986, specializing in semi-solid and liquid pharmaceutical products. Known for excellence and a global presence, Purna is a preferred partner for top pharma multinationals. We co-develop innovative products and offer them as commercial opportunities. Our 'customer intimacy' model ensures quick responses to various needs.   Successful projects are spun out for further development. For instance, in 2021, we created our first spin-out  ‘project FHP’ which is now preparing for phase 3 clinical studies after successfully completing phase 2 on 130 patients for the treatment of recurring vulvovaginal candidiasis.   Today we want to highlight a new therapeutic wound healing gel for diabetic ulcers showing up to 40% improvement in healing rate in validated animal models to spin off.   We are now seeking a partner to spin out this project, with Purna still providing further R&D, CMC development, registration, and project management services.